Compositions, methods of administration and uses for trivalent dengue virus formulations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9878031
APP PUB NO 20150335727A1
SERIAL NO

14652066

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Embodiments of the present invention report compositions and methods for vaccinating a subject using trivalent dengue virus vaccine compositions. In some embodiments, more than one vaccine composition may be administered to a subject in different anatomical locations in order to induce a rapid response to at least three of four dengue virus serotypes. In certain embodiments, administration of a trivalent dengue virus vaccine composition can be combined with administration of a monovalent dengue virus vaccine composition.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INVIRAGEN INC1613 PROSPECT PARKWAY SUITE 100 FORT COLLINS CO 80525

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brewoo, Joseph N Madison, US 11 38
Osorio, Jorge E Mount Horeb, US 29 95
Partidos, Charalambos D Chicago, US 7 35
Stinchcomb, Dan T Fort Collins, US 66 780

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 30, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 30, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00